Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Boston Life Sciences

Below is an extended Boston Life Sciences news listing. Click here to return to the Boston Life Sciences main Biocorporate entry.

BioNews Results for Boston Life Sciences:
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr PR Newswire: Nov 23 2009 12:47AM Matching: boston life sciences
Cambridge-based Ligon Discovery Raises $1M in Seed Funding BioSpace: Nov 21 2009 12:38AM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr Genetic Engineering News: Nov 21 2009 4:47AM Matching: boston life sciences
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News Xconomy: Nov 19 2009 7:14AM Matching: boston life sciences
YM Biosciences Announces Nimotuzumab Results In Advanced Triple-Negative Breast Cancer Model Presented At AACR Pharma Live: Nov 19 2009 9:15AM Matching: boston life sciences
Autism Consortium: Autism Consortium symposium draws record number of researchers, advocates, parents for autism update NewsRX: Nov 18 2009 6:17AM Matching: boston life sciences
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING CNW Telbec: Nov 18 2009 6:54PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr Reuters: Nov 18 2009 6:54PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr Charlotte Business Journal: Nov 18 2009 6:53PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr San Francisco Business Times: Nov 18 2009 6:50PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr KSLA: Nov 18 2009 6:50PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr Houston Chronicle: Nov 18 2009 6:23PM Matching: boston life sciences
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING Street Insider: Nov 18 2009 6:14PM Matching: boston life sciences
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr StockHouse USA: Nov 18 2009 6:11PM Matching: boston life sciences
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED PR Newswire via MSN Money: Nov 18 2009 6:00PM Matching: boston life sciences

«Boston Life Sciences

This page contained an extended Boston Life Sciences news listing. Click here to return to the Boston Life Sciences main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.